Literature DB >> 1567825

Cyclic AMP-dependent protein kinase controls basal gene activity and steroidogenesis in Y1 adrenal tumor cells.

C H Clegg1, M S Abrahamsen, J L Degen, D R Morris, G S McKnight.   

Abstract

Transfection of mouse Y1 adrenal tumor cells with DNA encoding mutant type I regulatory subunit generated stable transformants in which the basal activity of cAMP-dependent protein kinase was repressed. As expected, steroidogenesis in these kinase-deficient cells was no longer stimulated by corticotropin or cAMP analogues, and the expression of three cAMP-regulated genes (ornithine decarboxylase, urokinase-type plasminogen activator, and P450 side-chain cleavage) could no longer be induced. However, in addition to the loss of hormone responsiveness, the basal level of steroidogenesis and the constitutive expression of these cAMP-inducible genes was also repressed in kinase-defective mutant clones. To verify that functional cA-PK would revert this repressed phenotype, we transfected a cA-PK defective subclone of Y1 cells, Kin 8, with DNA encoding the C alpha and C beta subunits of cAMP-dependent protein kinase. Basal levels of steroid production were restored to normal in stable transformants, and the elevation of kinase activity following induction of the C-subunit expression vectors elicited a steroidogenic response. Gene transcription was also shown to be regulated by either C alpha or C beta as measured by the induction of plasminogen activator and ornithine decarboxylase mRNA levels and transcription rates. The dominant role played by cAMP-dependent protein kinase in these adrenal cells was demonstrated by experiments showing the regulation of ornithine decarboxylase gene expression by protein kinase C requires basal cAMP-dependent protein kinase activity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1567825     DOI: 10.1021/bi00129a023

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  7 in total

1.  Expression of Chinese hamster cAMP-dependent protein kinase in Escherichia coli results in growth inhibition of bacterial cells: a model system for the rapid screening of mutant type I regulatory subunits.

Authors:  M E Gosse; A Padmanabhan; R D Fleischmann; M M Gottesman
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

2.  Basal expression of the cystic fibrosis transmembrane conductance regulator gene is dependent on protein kinase A activity.

Authors:  R A McDonald; R P Matthews; R L Idzerda; G S McKnight
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-01       Impact factor: 11.205

3.  Studies of mice with cyclic AMP-dependent protein kinase (PKA) defects reveal the critical role of PKA's catalytic subunits in anxiety.

Authors:  George Briassoulis; Margaret F Keil; Bilal Naved; Sophie Liu; Matthew F Starost; Maria Nesterova; Nirmal Gokarn; Anna Batistatos; T John Wu; Constantine A Stratakis
Journal:  Behav Brain Res       Date:  2016-03-16       Impact factor: 3.332

4.  Effects of dehydroepiandrosterone on corticosterone release in rat zona fasciculata-reticularis cells.

Authors:  Ling-Ling Chang; Wan-Song Alfred Wun; L Low-Tone Ho; Paulus S Wang
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-11-13       Impact factor: 3.000

5.  The alternative Epac/cAMP pathway and the MAPK pathway mediate hCG induction of leptin in placental cells.

Authors:  Julieta Lorena Maymó; Antonio Pérez Pérez; Bernardo Maskin; José Luis Dueñas; Juan Carlos Calvo; Víctor Sánchez Margalet; Cecilia Laura Varone
Journal:  PLoS One       Date:  2012-10-02       Impact factor: 3.240

6.  Cell-type specific expression of a dominant negative PKA mutation in mice.

Authors:  Brandon S Willis; Colleen M Niswender; Thomas Su; Paul S Amieux; G Stanley McKnight
Journal:  PLoS One       Date:  2011-04-12       Impact factor: 3.240

7.  Activation and expression of endogenous CREB-regulated transcription coactivators (CRTC) 1, 2 and 3 in the rat adrenal gland.

Authors:  Lorna I F Smith; Zidong Zhao; Jamie Walker; Stafford Lightman; Francesca Spiga
Journal:  J Neuroendocrinol       Date:  2020-12-14       Impact factor: 3.627

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.